162 related articles for article (PubMed ID: 38057217)
1. In patients with neurological complications, SARS-CoV-2 infection must be confirmed by PCR.
Finsterer J
Brain Dev; 2024 Feb; 46(2):122-123. PubMed ID: 38057217
[No Abstract] [Full Text] [Related]
2. Neurological complications and infection mechanism of SARS-COV-2.
Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
[TBL] [Abstract][Full Text] [Related]
3. Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series.
Cleret de Langavant L; Petit A; Nguyen QTR; Gendre T; Abdelhedi J; Djellaoui A; Seddik L; Lim L; Faugeras F; Salhi H; Wahab A; Fechtenbaum L; Dormeuil A; Hosseini H; Youssov K; Fénelon G; Bapst B; Brugières P; Tuilier T; Kalsoum E; Matignon MB; Oniszczuk J; Gallien S; Vindrios W; Melica G; Scain AL; Esser R; Rostain L; Guillaud C; Dubos-Lascu G; Saada N; Guillet H; Khellaf M; Bardel B; Ayache SS; Lefaucheur JP; Pawlotsky JM; Fourati S; Bachoud-Lévi AC
Rev Neurol (Paris); 2021 Mar; 177(3):275-282. PubMed ID: 33610347
[TBL] [Abstract][Full Text] [Related]
4. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
[TBL] [Abstract][Full Text] [Related]
5. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
[TBL] [Abstract][Full Text] [Related]
7. Neurological complications of SARS-CoV-2 infection in children can be acute or post-acute.
Mehri S; Finsterer J
J Formos Med Assoc; 2024 Jul; 123(7):821-822. PubMed ID: 38627191
[No Abstract] [Full Text] [Related]
8. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
9. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B
Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076
[TBL] [Abstract][Full Text] [Related]
10. Neurological complications of a SARS-CoV-2 infection require a thorough and comprehensive evaluation.
Finsterer J
Eur J Pediatr; 2024 Jun; 183(6):2811-2812. PubMed ID: 38492033
[No Abstract] [Full Text] [Related]
11. Neurological Complications of COVID-19 in Children.
Ahmad S
Pediatr Ann; 2021 Jun; 50(6):e259-e263. PubMed ID: 34115563
[TBL] [Abstract][Full Text] [Related]
12. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
[TBL] [Abstract][Full Text] [Related]
13. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
LaRovere KL; Poussaint TY; Young CC; Newhams MM; Kucukak S; Irby K; Kong M; Schwartz SP; Walker TC; Bembea MM; Wellnitz K; Havlin KM; Cvijanovich NZ; Hall MW; Fitzgerald JC; Schuster JE; Hobbs CV; Halasa NB; Singh AR; Mack EH; Bradford TT; Gertz SJ; Schwarz AJ; Typpo KV; Loftis LL; Giuliano JS; Horwitz SM; Biagas KV; Clouser KN; Rowan CM; Maddux AB; Soma VL; Babbitt CJ; Aguiar CL; Kolmar AR; Heidemann SM; Harvey H; Zambrano LD; Campbell AP; Randolph AG;
JAMA Neurol; 2023 Jan; 80(1):91-98. PubMed ID: 36342679
[TBL] [Abstract][Full Text] [Related]
14. Assessment of neurological manifestations in hospitalized patients with COVID-19.
Luigetti M; Iorio R; Bentivoglio AR; Tricoli L; Riso V; Marotta J; Piano C; Primiano G; Zileri Del Verme L; Lo Monaco MR; Calabresi P;
Eur J Neurol; 2020 Nov; 27(11):2322-2328. PubMed ID: 32681611
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity and SARS-CoV-2 infection: Unraveling the link in neurological disorders.
Latorre D
Eur J Immunol; 2022 Oct; 52(10):1561-1571. PubMed ID: 35833748
[TBL] [Abstract][Full Text] [Related]
17. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
18. Neurological infection and complications of SARS-CoV-2: A review.
Singh S; Meher N; Mohammed A; Razab MKAA; Bhaskar LVKS; Nawi NM
Medicine (Baltimore); 2023 Feb; 102(5):e30284. PubMed ID: 36749239
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability of COVID-19 and Neurological Complications: A Review.
Moore P; Esmail F; Qin S; Nand S; Berg S
J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106163. PubMed ID: 34763262
[TBL] [Abstract][Full Text] [Related]
20. [Ataxia, Involuntary Movement and Paroxysmal Motor Abnormality Associated with COVID-19 Infection].
Takahashi M
Brain Nerve; 2022 Jul; 74(7):861-866. PubMed ID: 35860932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
